NCT04466384View on ClinicalTrials.gov

Bispectral Index and Levels of Sedation With Propofol With/Without Remifentanil in Healthy Volunteers (SONORA)

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

March 3, 2021

Study Completion Date

March 3, 2021

Conditions
Anesthesia
Interventions
DEVICE

BIS

Subjects will be sequentially assigned to the propofol or propofol and remifentanil group. The purpose is to capture the BIS value in association with these anesthetics.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Medtronic - MITG
All Listed Sponsors
lead

Medtronic - MITG

INDUSTRY

NCT04466384 - Bispectral Index and Levels of Sedation With Propofol With/Without Remifentanil in Healthy Volunteers (SONORA) | Biotech Hunter | Biotech Hunter